A phase 2, randomized, double-blind, placebo-controlled study of ubenimex in patients with pulmonary arterial hypertension (WHO Group 1) (LIBERTY)

Administered By

Medicine, Cardiology

Awarded By

Eiger BioPharmaceuticals, Inc.

Contributors

Rajagopal, Sudarshan Principal Investigator

Start/End

June 1, 2016 - December 31, 2018